Daily insulin injections make it hard
for many diabetics to control blood sugar well enough to prevent serious complications like blindness and kidney failure. Now Pfizer and Sanofi-Aventis offer up the painless Exubera, an inhaler that delivers aerosolized insulin to the lungs, which quickly absorb the drug over their large surface area. A single puff just before meals can stabilize blood sugar as effectively as a shot. A Food and Drug Administration panel voted to approve Exubera this fall based on results from more than 52 clinical trials conducted over 10 years.
138 years of Popular Science at your fingertips.
Each issue has been completely reimagined for your iPad. See our amazing new vision for magazines that goes far beyond the printed page
Stay up to date on the latest news of the future of science and technology from your iPhone or Android phone with full articles, images and offline viewing
Featuring every article from the magazine and website, plus links from around the Web. Also see our PopSci DIY feed
Science is reinventing play, from extreme sports to gamification to ridiculous roller coasters to the playgrounds of tomorrow, and this issue is chock full of fun. Also, on a less fun note: Did global warming destroy my hometown?